Basophil activation test in allergy diagnostics

REVIEW ARTICLE

Basophil activation test in allergy diagnostics

Karolina Nowakowska 1 , Emilia Królewicz 2 , Andrzej Gamian 2 , Wojciech Barg 1

1. Katedra i Klinika Chorób Wewnętrznych, Pneumonologii i Alergologii, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu,
2. Katedra i Zakład Biochemii Lekarskiej, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu,

Published: 2020-12-11
DOI: 10.5604/01.3001.0014.5766
GICID: 01.3001.0014.5766
Available language versions: en pl
Issue: Postepy Hig Med Dosw 2020; 74 : 548-555

 

Abstract

The prevalence of allergic diseases in Poland and in the world continues to rise in recent years. The most commonly used methods for diagnosing IgE – dependent allergies are skin prick testing (SPT) and assessment of specific IgE (sIgE) directed against specific allergens. However, both methods have some disadvantages and the obtained results may be inconsistent. In particular, routine diagnostic tests are not always effective for some drugs and foods. Consequently, additional laboratory tools should be used. Basophil activation test (BAT) based on flow cytometry is a promising diagnostic method. The present paper demonstrates the usefulness and effectiveness of BAT protocols in allergy diagnosis in scientific research. In comparison to routinely used diagnostic methods, BAT is an expensive and complicated laboratory tool. However, it offers the possibility to efficiently and effectively recognize allergies. Introducing BAT into routine diagnostics in allergology is problematic because this method has not yet been standardized and validated. Therefore, there is a justified need to continue research in this field. If standardized and validated, BAT may offer a reasonable improvement in allergy diagnostics in the future.

References

  • 1. Ansotegui I., Melioli G., Canonica G.W., Caraballo L., Villa E.,Ebisawa M., Passalacqua G., Savi E., Ebo D., Gómez R.M., LuengoSánchez O., Oppenheimer J.J., Jensen-Jarolim E., Fischer D.A.,Haahtela T. i wsp.: IgE allergy diagnostics and other relevant testsin allergy, a World Allergy Organization position paper. World AllergyOrgan. J., 2020; 13: 100080
    Google Scholar
  • 2. Appel M.Y., Nachshon L., Elizur A., Levy M.B., Katz Y., GoldbergM.R.: Evaluation of the basophil activation test and skin prick testingfor the diagnosis of sesame food allergy. Clin. Exp. Allergy,2018; 48: 1025–1034
    Google Scholar
  • 3. Ariza A., Fernandez T.D., Doña I., Aranda A., Blanca-Lopez N.,Melendez L., Canto G., Blanca M., Torres M.J., Mayorga C.: Basophilactivation after nonsteroidal anti-inflammatory drugs stimulationin patients with immediate hypersensitivity reactions to thesedrugs. Cytometry A, 2014; 85: 400–407
    Google Scholar
  • 4. Balzer L., Pennino D., Blank S., Seismann H., Darsow U., SchnedlerM., McIntyre M., Ollert M.W., Durham S.R., Spillner E., Ring J.,Cifuentes L.: Basophil activation test using recombinant allergens:Highly specific diagnostic method complementing routine tests inwasp venom allergy. PLoS One, 2014; 9: e108619
    Google Scholar
  • 5. Barg W.: Annexin-V binding assay as a marker for the activationof a basophil induced by specific allergens. DSc thesis. Wroclaw:Wroclaw Medical University, 2015, Poland
    Google Scholar
  • 6. Bidad K., Nawijn M.C., Van Oosterhout A.J., Van Der Heide S.,Elberink J.N.: Basophil activation test in the diagnosis and monitoringof mastocytosis patients with wasp venom allergy on immunotherapy.Cytometry B Clin. Cytom., 2014; 86: 183–190
    Google Scholar
  • 7. Bousquet J., Heinzerling L., Bachert C., Papadopoulos N.G., BousquetP.J., Burney P.G., Canonica G.W., Carlsen K.H., Cox L., HaahtelaT., Lodrup Carlsen K.C., Price D., Samolinski B., Simons F.E., WicknamM. i wsp.: Practical guide to skin prick tests in allergy to aeroallergens.Allergy, 2012; 67: 18–24
    Google Scholar
  • 8. Calabria C.W., Hagan L.: The role of intradermal skin testingin inhalant allergy. Ann. Allergy. Asthma. Immunol., 2008; 101:337–347
    Google Scholar
  • 9. Chinthrajah R.S., Purington N., Andorf S., Rosa J.S., Mukai K.,Hamilton R., Smith B.M., Gupta R., Galli S.J., Desai M., Nadeau K.C.:Development of a tool predicting severity of allergic reaction duringpeanut challenge. Ann. Allergy Asthma Immunol., 2018; 121:69–76.e2
    Google Scholar
  • 10. Chirumbolo S.: Immunotherapy in allergy and cellular tests:State of art. Hum. Vaccin. Immunother., 2014; 10: 1595–1610
    Google Scholar
  • 11. Chirumbolo S., Ortolani R., Vella A.: CCR3 as a single selectionmarker compared to CD123/HLADR to isolate basophils inflow cytometry: Some comments. Cytometry A, 2011; 79: 102–106
    Google Scholar
  • 12. Couto M., López-Salgueiro R., Gaspar Â.: Anaphylaxis to Etoricoxib.J. Investig. Allergol. Clin. Immunol., 2018; 28: 135–136
    Google Scholar
  • 13. Curto-Barredo L., Yelamos J., Gimeno R., Mojal S., Pujol R.M.,Giménez-Aarnau A.: Basophil activation test identifies the patientswith chronic spontaneous urticaria suffering the most active disease.Immun. Inflamm. Dis., 2016; 4: 441–445
    Google Scholar
  • 14. Czarnobilska E.M., Bulanda M., Śpiewak R.: The usefulness ofthe basophil activation test in monitoring specific immunotherapywith house dust mite allergens. Postępy Dermatol. Alergol.,2018; 35: 93–98
    Google Scholar
  • 15. Deng S., Yin J.: Clinical utility of basophil activation test in diagnosisand predicting severity of mugwort pollen-related peachallergy. World. Allergy. Organ. J., 2019; 12: 100043
    Google Scholar
  • 16. Dewachter P., Chollet-Martin S., Mouton-Faivre C., DeChaisemartin L., Nicaise-Roland P.: Comparison of basophil activationtest and skin testing performances in NMBA allergy. J. Allergy.Clin. Immunol. Pract., 2018; 6: 1681–1689
    Google Scholar
  • 17. Eberlein B., Hann R., Eyerich S., Pennino D., Ring J., Schmidt-Weber C.B., Buters J.: Optimizing of the basophil activation test:Comparison of different basophil identification markers. CytometryB. Clin. Cytom., 2015; 88: 183–189
    Google Scholar
  • 18. Eberlein B., Krischan L., Darsow U., Ollert M., Ring J.: Doublepositivity to bee and wasp venom: Improved diagnostic procedureby recombinant allergen–based IgE testing and basophil activationtest including data about cross-reactive carbohydrate determinants.J. Allergy. Clin. Immunol., 2012; 130: 155–161
    Google Scholar
  • 19. Eberlein-König B., Varga R., Mempel M., Darsow U., BehrendtH., Ring J.: Comparison of basophil activation tests using CD63 orCD203c expression in patients with insect venom allergy. Allergy,2006; 61: 1084–1085
    Google Scholar
  • 20. Ebo D.G., Bridts C.H., Hagendorens M.M., De Clerck L.S., StevensW.J.: Scampi allergy: From fancy name-giving to correct diagnosis.J. Investig. Allergol. Clin. Immunol., 2008; 18: 228–230
    Google Scholar
  • 21. Ebo D.G., Faber M., Elst J., Van Gasse A.L., Bridts C.H., MertensC., De Clerck L.S., Hagendorens M.M., Sabato V.: In vitro diagnosisof immediate drug hypersensitivity during anesthesia: A review ofthe literature. J. Allergy. Clin. Immunol. Pract., 2018; 6: 1176–1184
    Google Scholar
  • 22. Fernández T.D., Ariza A., Palomares F., Montañez M.I., Salas M.,Martin-Serrano A., Fernández R., Ruiz A., Blanca M., Mayorga C.,Torres M.J.: Hypersensitivity to fluoroquinolones: The expressionof basophil activation markers depends on the clinical entity andthe culprit fluoroquinolone. Medicine, 2016; 95: e3679
    Google Scholar
  • 23. Giorgis V., Rolla G., Raie A., Geuna M., Boita M., Lamberti C.,Nebbia S., Giribaldi M., Giuffrida M.G., Brussino L., Corradi F., BaccoB., Gallo Cassarino S., Nicola S., Cavallarin L.: A case of workrelateddonkey milk allergy. J. Investig. Allergol. Clin. Immunol.,2018; 28: 197–199
    Google Scholar
  • 24. Gómez E., Campo P., Rondón C., Barrionuevo E., Blanca-LópezN., Torres M.J., Herrera R., Galindo L., Mayorga C., Blanca M.: Roleof the basophil activation test in the diagnosis of local allergic rhinitis.J. Allergy Clin. Immunol., 2013; 132: 975–976.e1-5
    Google Scholar
  • 25. Goswami K., Mazumdar I., Mookherje S., Pal P.: Qualitativeassessment of allergen skin test and in vitro allergen specific immunoglobulinE (IgE) measurement as a method of detection of allergicsymptoms. Int. J. Curr. Microbiol. App. Sci., 2016; 5: 614–619
    Google Scholar
  • 26. Gutiérrez-Fernandez D., Saldaña-Valderas M., De La Varga-Martínez R., Foncubierta-Fernández A., Fernández-Anguita M.J.,Fernández-Valle M.D., Medina-Varo F.: Hypersensitivity to alemtuzumab.A safe and effective desensitization protocol: A case report.J. Oncol. Pharm. Pract., 2019; 25: 1016–1020
    Google Scholar
  • 27. Hagau N., Gherman-Ionica M., Sfichi M., Petrisor C.: Thresholdfor basophil activation test positivity in neuromuscular blockingagents hypersensitivity reactions. Allergy Asthma Clin. Immunol.,2013; 9: 42
    Google Scholar
  • 28. Hausmann O.V., Gentinetta T., Fux M., Ducrest S., Pichler W.J.,Dahinden C.A.: Robust expression of CCR3 as a single basophil selectionmarker in flow cytometry. Allergy, 2011; 66: 85–91
    Google Scholar
  • 29. Hayen S.M., Den Hartog Jager C.F., Knulst A.C., Knol E.F., GarssenJ., Willemsen L., Otten H.G.: Non-digestible oligosaccharidescan suppress basophil degranulation in whole blood of peanutallergicpatients. Front. Immunol., 2018; 9: 1265
    Google Scholar
  • 30. Heinzerling L., Mari A., Bergmann K.C., Bresciani M., BurbachG., Darsow W., Durham S., Fokkens W., Gjomarkaj M., Haahtela T.,Bom A.T., Wöhrl S., Maibach H., Lockey R.: The skin prick test –European standards. Clin. Trans. Allergy, 2013; 3: 3
    Google Scholar
  • 31. Hemmings O., Kwok M., McKendry R., Santos A.F.: Basophilactivation test: Old and new applications in allergy. Curr. AllergyAsthma Rep., 2018; 18: 77
    Google Scholar
  • 32. Hoffmann H.J., Knol E.F., Ferrer M., Mayorga L., Sabato V., SantosA.F., Eberlein B., Nopp A., MacGlashan D.: Pros and cons of clinicalbasophil testing (BAT). Curr. Allergy Asthma Rep., 2016; 16: 56
    Google Scholar
  • 33. Hoffmann H.J., Santos A.F., Mayorga C., Nopp A., Eberlein B.,Ferrer M., Rouzaire P., Ebo D.G., Sabato V., Sanz M.L., Pecaric-PetkovicT., Patil S.U., Hausmann O.V., Shreffler W.G., Korosec P., KnolE.F.: The clinical utility of basophil activation testing in diagnosisand monitoring of allergic disease. Allergy, 2015; 70: 1393–1405
    Google Scholar
  • 34. Kahlert H., Cromwell O., Fiebig H.: Measurement of basophilactivatingcapacity of grass pollen allergens, allergoids and hypoallergenicrecombinant derivatives by flow cytometry usinganti-CD203c. Clin. Exp. Allergy, 2003; 33: 1266–1272
    Google Scholar
  • 35. Kim Z., Choi B.S., Kim J.K., Won D.I.: Basophil markers for identificationand activation in the indirect basophil activation test byflow cytometry for diagnosis of autoimmune urticaria. Ann. Lab.Med., 2016; 36: 28–35
    Google Scholar
  • 36. Korošec P., Šilar M., Eržen R., Čelesnik N., Bajrović N., ZidarnM., Košnik M.: Clinical routine utility of basophil activation testingfor diagnosis of hymenoptera-allergic patients with emphasison individuals with negative venom-specific IgE antibodies. Int.Arch. Allergy Immunol., 2013; 161: 363–368
    Google Scholar
  • 37. Królewicz E., Gomułka K., Wolańczyk-Mędrala A., MędralaW., Barg W., Kustrzeba-Wójcicka I.: The diagnostic usefulness ofthe basophil activation test (BAT) with annexin V in an allergyto Alternaria alternata. Adv. Clin. Exp. Med., 2018; 27: 1737–1744
    Google Scholar
  • 38. MacGlashan D.Jr.: Expression of CD203c and CD63 in humanbasophils: Relationship to differential regulation of piecemeal andanaphylactic degranulation processes. Clin. Exp. Allergy, 2010; 40:1365–1377
    Google Scholar
  • 39. Marraccini P., Pignatti P., D Apos Alcamo A.D., Salimbeni R.,Consonni D.: Basophil activation test application in drug hypersensitivitydiagnosis: An empirical approach. Int. Arch. Allergy.Immunol., 2018; 177: 160–166
    Google Scholar
  • 40. Nopp A., Johansson S.G., Ankerst J., Bylin G., Cardell L.O., GrönnebergR., Irander K., Palmqvist M., Oman H.: Basophil allergenthreshold sensitivity: A useful approach to anti-IgE treatment efficacyevaluation. Allergy, 2006; 61: 298–302
    Google Scholar
  • 41. Nowakowska K., Królewicz E., Barg W.: The comparison ofbasophil activation tests with annexin V and CD63 in house dustmite allergy. W: Ìmunopatologìâ pri zahvorûvannâh organìv dihannâì travlennâ: mìžnarodna pul’monologìčna škola. MaterìaliVI naukovogo simpozìumu. Ternopìl, Ukraïna, 20–22 veresnâ 2018roku; 50: 77–78
    Google Scholar
  • 42. Ogulur I., Kiykim A., Baris S., Ozen A., Yuce E.G., Karaok-AydinerE.: Basophil activation test for inhalant allergens in pediatricpatients with allergic rhinitis. Int. J. Pediatr. Otorhinolaryngol.,2017; 97: 197–201
    Google Scholar
  • 43. Ornelas C., Caiado J., Campos Melo A., Pereira Barbosa M.,Castells M.C., Pereira Dos Santos M.C.: The contribution of thebasophil activation test to the diagnosis of hypersensitivity reactionsto oxaliplatin. Int. Arch. Allergy Immunol., 2018; 177: 274–280
    Google Scholar
  • 44. Özdemir S.K., Göloğlu D., Sin B.A., Elhan A.H., IkincioğullarıA., Mısırlıgil Z.: Reliability of basophil activation test using CD203cexpression in diagnosis of pollen allergy. Am. J. Rhinol. Allergy,2011; 25: e225–e231
    Google Scholar
  • 45. Ruinemas-Koerts J., Schmidt-Hieltjes Y., Jansen A., SavelkoulH.F., Plaisier A., Van Setten P.: The basophil activation test reduces the need for a food challenge test in children suspected of IgEmediatedcow’s milk allergy. Clin. Exp. Allergy, 2019; 49: 350–356
    Google Scholar
  • 46. Sainte-Laudy J., Vallon C., Guérin J.C.: Analysis of membraneexpression of the CD63 human basophil activation marker. Applicationsto allergologic diagnosis. Allerg. Immunol., 1994; 26: 211–214
    Google Scholar
  • 47. Salas M., Gomez F., Fernandez T.D., Doña I., Aranda A., ArizaA., Blanca-Lopéz N., Mayorga C., Blanca M., Torres M.J.: Diagnosisof immediate hypersensitivity reactions to radiocontrast media.Allergy, 2013; 68: 1203–1206
    Google Scholar
  • 48. Samoliński B., Raciborski F., Lipiec A., Tomaszewska A., Krzych-Fałta E., Samel-Kowalik P., Walkiewicz A., Lusawa A., Borowicz J.,Komorowski J., Samolińska-Zawisza U., Sybilski A.J., Piekarska B.,Nowicka A.: Epidemiology of allergic diseases in Poland. Pol. J. Allergol.,2014; 1: 10–18
    Google Scholar
  • 49. Santos A.F., Douiri A., Bécares N., Wu S.Y., Stephens A., RadulovicS., Chan S.M., Fox A.T., Du Toitt G., Turcanu V., Lack G.: Basophilactivation test discriminates between allergy and tolerancein peanut–sensitized children. J. Allergy. Clin. Immunol., 2014;134: 645–652
    Google Scholar
  • 50. Sato S., Yanagida N., Ebisawa M.: How to diagnose food allergy.Curr. Opin. Allergy. Clin. Immunol., 2018; 18: 214–221
    Google Scholar
  • 51. Scherer K., Weber J.M., Jermann T.M., Krautheim A., Tas E.,Uueberschlag E.V., Cammarata M., Bircher A.J.: Cellular in vitroassays in the diagnosis of Hymenoptera venom allergy. Int. Arch.Allergy. Immunol., 2008; 146: 122–132
    Google Scholar
  • 52. Skotny A.: Annexin–V binding assay on the basophil surface inthe diagnosis of rye allergy. PhD Dissertation. Wroclaw: WroclawMedical University 2016, Poland
    Google Scholar
  • 53. Sokolowska M., Boonpiyathad T., Escribese M.M., Barber D.:Allergen‐specific immunotherapy: Power of adjuvants and novelpredictive biomarkers. Allergy, 2019; 74: 2061–2063
    Google Scholar
  • 54. Sturm G.J., Jin C., Kranzelbinder B., Hemmer W., Sturm E.M.,Griesbacher A., Heinemann A., Vollmann J., Altmann F., CrailsheimK., Focke M., Aberer W.: Inconsistent results of diagnostic toolshamper the differentiation between bee and vespid venom allergy.PLoS One, 2011; 6: e20842
    Google Scholar
  • 55. Tokuda R., Nagao M., Hiraguchi Y., Hosoki K., Matsuda T., KounoK., Morita E., Fujisawa T.: Antigen–induced expression of CD203con basophils predicts IgE–mediated wheat allergy. Allergol. Int.,2009; 58: 193–199
    Google Scholar
  • 56. Uasuf C.G., Sano C.D., Gangemi S., Albeggiani G., Cigna D., DinoP., Brusca I., Gjomarkaj M., Pace E.: IL–33/s–ST2 ratio, systemicsymptoms, and basophil activation in Pru p 3–sensitized allergicpatients. Inflamm. Res., 2018; 67: 671–679
    Google Scholar
  • 57. Uyttebroek A.P., Sabato V., Cop N., Decuyper I.I., Faber M.A.,Bridts C.H., Mertens C., Hagendorens M.M., De Clerck L.S., Ebo D.G.:Diagnosing cefazolin hypersensitivity: Lessons from dual–labelingflow cytometry. J. Allergy Clin. Immunol. Pract., 2016; 4: 1243–1245
    Google Scholar
  • 58. Wolanczyk–Medrala A., Barg W., Medrala W.: CD164 as a basophilactivation marker. Curr. Pharm. Des., 2011; 17: 3786–3796
    Google Scholar
  • 59. Zenarruzabeitia O., Vitallé J., Terrén I., Orrantia A., AstigarragaI., Dopazo L., Gonzalez C., Santos–Díez L., Tutau C., GamboaP.M., Bilbao A., Borrego F.: CD300c costimulates IgE–mediated basophilactivation, and its expression is increased in patients withcow’s milk allergy. J. Allergy Clin. Immunol., 2019; 143: 700–711.e5
    Google Scholar
  • 60. Žitnik S.E., Vesel T., Avčin T., Šilar M., Košnik M., Korošec P.:Monitoring honeybee venom immunotherapy in children withthe basophil activation test. Pediatr. Allergy Immunol., 2012; 23:166–172
    Google Scholar

Full text

Skip to content